Overview

Placebo-controlled Trial in Subjects at Ultra-high Risk for Psychosis With Omega-3 Fatty Acids in Europe

Status:
Active, not recruiting
Trial end date:
2023-01-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether omega-3 fatty acids are effective in the prevention of psychosis in individuals at ultra-high risk for psychosis.
Phase:
Phase 4
Details
Lead Sponsor:
Rene Kahn